Business
Goldman Sachs names Healius (ASX:HLS) as a value share to buy
The Healius Ltd (ASX: HLS) share price was a particularly positive performer on Wednesday.
The healthcare company’s shares jumped 7.5% to $3.90 following the release of a positive trading update.
What was in the Healius update?
As you might have guessed from the Healius share price reaction, the company has been performing very positively so far in FY 2021.
Healius advised that its Pathology business continued its strong revenue growth in October and November thanks to a combination of COVID-19 testing and non-COVID revenue growth.
The Imaging and Day Hospitals businesses were also performing positively, with growth being delivered across all states.
This strong form and the recent completion of its medical centres sale to BGH…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor